New drugs for small animals in 2020

摘要

In 2020, one novel pharmaceutical agent for small animals, the ACTH analog tetracosactide for the assessment of adrenocortical function in dogs, were released on the German market. Two established veterinary active pharmaceutical ingredients became available for additional species: The dissociative anesthetic ketamine is now also authorized for hamsters, mice, and rats; and the osmotic laxative lactulose is approved for use also in dogs and cats. Additionally, 3 veterinary drugs with a new combination of active ingredients (mometasone + terbinafine + florfenicol, sarolaner + moxidectin + pyrantel), an agent (tetracaine) in a novel pharmaceutical formulation, one drug (lidocaine) with a new route of administration as well as a crystalloid balanced whole electrolyte solution with a potential base excess (BEpot) of 0 mmol/l were launched on the market for small animals.